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Abstract
Key positive outcomes for hospice patients include the prevention and alleviation
of physical and psychological distress, maintenance of physical and mental functioning
and all aspects of quality of life. This research used secondary analysis of previously
gathered data to answer new research questions with alternative strategies to examine
relationships not previously analyzed. The researchers collected data from 717 cancer
patients who had been admitted to one of two private hospices. The aim of their
experimental intervention was to define the effectiveness of using standardized
assessment tools to provide systematic feedback to hospice staff about hospice patients
and their caregivers. The aim of this secondary analysis was to assess the mediating
effect of constipation distress on the relationship between constipation intensity and the
hospice patients’ QOL. Variables included in the analysis were: Quality of Life,
Constipation Distress, Sociodemographic Characteristics (Age, gender, marital status,
race/ culture, education, and socioeconomic status), Clinical Characteristics (Type of
cancer, Co-morbidities, Functional/mental Health status), and Constipation Intensity.
The data analyzed using descriptive statistics, including the frequency,
percentage, means and standard deviation for quality of life. A relationship between
quality of life and sociodemographic variables and between quality of life and clinical
characteristics were evaluated with Pearson correlation coefficients. An exploratory
mediation analysis was used to assess the mediation effect of the constipation distress.
v

Results showed that age, ethnicity, constipation severity and functional status
were predictors of QOL (P<0.0), and the bootstrapping showed that constipation distress
has a mediation effect on the relationship between constipation severity and quality of
life. The symptom intensity and distress as well as the relationship between constipation
and quality of life need to be seen in a holistic approach to achieve the best symptom
management for cancer patients.
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Chapter One: Introduction
Globally, cancer is recognized as a major public health concern. According to the
American Cancer Society, more than 1.5 million new cancer cases and 570,000 cancerrelated deaths occur annually in the United States (Jemal, et al., 2008). Constipation is a
common problem for cancer patients, and is a frequent adverse effect of cancerassociated pain treatment with opioid analgesics (Mercadante, Ferrera, & Casuccio,
2011). Constipation increases the burden on cancer patients by affecting their overall
quality of life (QOL) and increasing their level of pain and distress. As a result of severe
constipation, patients complain of gastrointestinal tract problems such as vomiting and
hemorrhoids which lead to increased emergency room visits and hospitalizations.
Constipation burden does not affect the patient alone ; it also increases the burden on the
families as well as health care system costs (Librach, et al., 2010).
More than 60% of patients with constipation are inadequately treated because of
the under-estimation of constipation intensity and ineffective treatment. In some cases,
no treatment is given at all (Laugsand, Jakobsen, Kaasa, & Klepstad, 2010). It is
estimated that more than 40% of cancer patients with opioid-related constipation may not
be receiving laxatives as prophylaxis, and their constipation may not be managed
properly. These patients report discomfort, distress and pain (Wee, et al., 2010). Patients
with severe constipation have a lower QOL and higher treatment costs (Hjalte,
Berggren, Bergendahl, & Hjortsberg, 2010).
1

Constipation is a serious problem for cancer patients near the end of life, but the
literature does not address the distress caused by constipation and the effect of this
distress on the QOL of patients with advanced cancer. Symptom distress is a component
of the broader, multidimensional construct of the symptom experience (Goodell & Nail,
2005). Symptom distress is the degree of discomfort associated with a symptom as
experienced by the patient, and it reflects the patient's interpretation of a symptom
(Molassiotis, Wengstrom, & Kearney, 2010). Symptom distress is defined as "the degree
of perceived discomfort experienced in relation to a symptom" (Cimprich, 1999).
The patient’s experience of symptoms consists of physiological and psychological
dimensions, this is why patients develop a response to their symptoms based on what
meaning they attribute to them. One of the main dimensions of the symptom experience
is distress. Higher levels of symptoms severity have been predictive of higher levels of
symptom distress and poor quality of life (Bevans, Mitchell, & Marden, 2008).
Patients' symptom experiences are known to be their perception and response to
symptom occurrence and symptom distress. Symptom occurrence measures the
prevalence of the symptom. Symptom distress is the amount of physical and/or mental
upset that patient’s experience (Rhodes, McDaniel, Matthews 1998). QOL is a
multifaceted concept with a variety of domains. Depending on the investigators, these
domains might include psycho-physiological, functional, and social/spiritual well-being
(Aaronson et al., 1993, Cohen et al., 1997, Ferrans, 1990; McMillan et al., 2006).
Palliative care and hospices have developed rapidly since the late 1960s. The
pioneering work of Dr. Cicely Saunders was instrumental in drawing attention to the end-
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of-life care needs of patients with advanced malignant disease. Palliative care began to be
defined in the 1970s and came to be synonymous with the physical, social, psychological,
and spiritual support of patients and significant others with life-limiting illness, delivered
by a multidisciplinary team. Palliative care services have developed in many settings and
have often been closely related to oncology. The global need for this type of care remains
much greater than what is currently available. However, there are encouraging signs of
recognition by policymakers and influential bodies, and interest in palliative care has
never been greater (Clark, 2007).
Hospices provide palliative care with the goal of improving patient QOL. A
critical component in improving QOL is aggressive management of physical symptoms.
Physical symptoms most commonly experienced by cancer patients are reported to
include fatigue, dyspnea, pain and constipation (Donnelly & Walsh, 1995; Weitzner,
Moody & McMillan, 1997). Constipation causes some degree of symptom distress and
has a negative effect on the patient’s overall QOL. In a study of 393 patients with cancer,
patients ranked constipation control as sixth in importance out of 25 items related to
overall QOL (Stark, Tofthagen, Visovsky, & McMillan, 2012 ). Uncontrolled symptoms
clearly have a negative impact on all aspects of QOL, including emotional and spiritual
well-being, social relationships, and functional ability (Kurtz, Kurtz, Given, & Given,
1993; McMillan & Weitzner, 1998). Most clinicians and researchers agree that
improvement in the patient's QOL is the ultimate goal in care of cancer patients near the
end of life, and this is consistent with the approach of the World Health Organization
(WHO). The expected outcome of palliative and hospice care is to control patients’
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symptoms to ensure a high level of QOL in all it is dimensions (Berger, Shuster, & Von
Roenn, 2006).
Palliative care is a young discipline for research, though expert opinions have
been helpful. The lack of extended research programs addressing basic biological
mechanisms of patients with advanced disease and short life expectancy nationally has
created an increasingly strong call for research in palliative care. Obstacles and
challenges include ethical concerns about collecting data from these very ill patients,
establishment of a research agenda, the number of experienced researchers available at
the university level, and funding for palliative care research. Committed individuals have
conducted important research, and if their efforts are combined with professional
leadership, funding might be secured to establish the programs necessary to address
palliative care research (Kaasa & Dale, 2005).
Statement of the Problem
Constipation is among the more common symptoms that require recognition and
treatment, and one that is known to be negatively correlated with quality of life
(McMillan & Weitzner, 1998). The literature addressing whether there is an effect of
constipation distress as a predictor of hospice patient’s quality of life is very limited,
despite it being a significant problem for cancer patients near the end of life. Crucial
positive outcomes for hospice patients include prevention and alleviation of physical and
psychological distress, maintenance of physical and mental functioning and support for
all aspects of QOL. Nurses encounter patients with constipation in a variety of practice
settings; and have a pivotal role in identifying patients at risk and implementing
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evidence-based interventions (Woolery et al 2008). Nurses are instrumental in control of
constipation, and enhancing QOL in patients with advanced cancer (Fredericks, Hollis, &
Stricker, 2010). The purpose of the proposed study was to determine, using an existing
data set, predictors of QOL and to evaluate the mediating effect of constipation distress in
patients who receive homecare from a large nonprofit hospice.
Research Questions
This study addressed the following questions:
1.

Do socio-demographic variables (age, gender, marital status, race/culture,
education, and socioeconomic status), clinical characteristics (type of cancer,
physical and mental status) and constipation intensity predict quality of life
in hospice patients with cancer?

2.

To what extent does constipation distress serve as a mediator in the
relationship between constipation intensity and overall quality of life in
hospice patients with cancer?

Conceptual Framework

Constipation causes symptom distress and has a negative effect on the patient’s
overall QOL. This framework posits that there is a direct path and effect between
constipation intensity and the patient’s overall QOL with and without the distress being a
mediator in the relationship. In the past, the social sciences considered the terms
mediator and moderator to be synonymous (Baron & Kenny, 1986). Contemporary
thought considers mediation as a variable that accounts for all or part of the relationship
5

between a predictor variable and outcome. A mediator also can be explained as a
transmitter of the effect of an independent variable (IV) on a dependent variable (DV). So
the IV affects the DV because the IV affects the mediator, and the mediator in sequence
affects the DV. (Preacher, Rucker, & Hayes, 2007). Statistical significance of the
mediated effect can be calculated by dividing the estimate by its standard error and
comparing the result with the standard normal distribution. For non-normality of data,
both confidence limits for mediated effects and resampling methods could be used
(MacKinnon & Fairchild, 2009).

The aim of end of life care is to enhance QOL for patients; QOL is valued as a
primary outcome. Several domains contribute to an individual’s overall QOL. These
include psychophysiological, functional, and social/spiritual well-being (McMillan &
Weitzner, 1998). A conceptual framework for evaluating QOL of cancer patients is very
important because it structures assessment of all domains and predictors and can quantify
an individual patient's QOL through sociodemographic and clinical characteristics. In
addition, it may determine relationships between symptom distress caused by
constipation and cancer patient's quality of life.

Definition of Variables

For the purpose of this study the following terms are defined:

1.

Quality of Life (QOL) is a multifaceted concept with a variety of domains.

For the purpose of this research, these domains include psychophysiological, functional,
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and social /spiritual well-being (Aaronson et al., 1993, Cohen et al., 1997, Ferrans, 1990;
McMillan et al., 2006).

Figure 1 Conceptual framework

2.

Patients' symptom experiences are known to be their perception and response

to symptom occurrence and symptom distress.

3.

Symptom occurrence is the frequency and severity of the symptom.
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4.

Symptom distress is the amount of physical and/or mental upset that may

experience by patients (Rhodes, McDaniel, Matthews 1998). Symptom distress is a
component of the broader, multidimensional construct of the symptom experience
(Goodell& Nail, 2005). Symptom distress is known as the degree of discomfort
associated with a symptom as experienced by the patient, and it reflects the patient's
interpretation of a symptom (Molassiotis, et al., 2010). Symptom distress also is defined
as "the degree of perceived discomfort experienced in relation to a symptom" (Cimprich,
1999).
Significance of the Study
There is a paucity of extant literature addressing the effect of constipation as a
predictor on hospice patient’s quality of life However, constipation is a significant
problem for cancer patients near the end of life (Garrison, Overcash, & McMillan, 2011).
Expert opinion has been always useful for the palliative care discipline because so few
studies have been conducted in this population; this highlighted the importance of having
more research on the national level (Kaasa & Dale, 2005).
Results of this secondary analysis may provide nurses with more knowledge
about the impact of symptom distress in cancer patients, and its relationship with cancer
patient's quality of life. Availability of skillful supportive care is a right for cancer

patients near the end of life and their families. Results of this study may influence
curricular changes. In the field of education, both educators and professionals should start
to change the curriculum for all university levels; graduate and undergraduate, and for
continuing education departments at hospitals and hospices to insure that health care
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provider's skills and knowledge are based on evidence. Nurses and other health care
providers should be committed to improving care for their patients and alleviating
suffering for cancer patients near the end of life by managing their symptoms.

9

Chapter Two: Review of Literature

The literature review is divided into four sections: First, predictors of QOL are
addressed; second, symptom distress and QOL in cancer patients near the end of life are
discussed. The third section of the literature review addresses constipation and cancer,
and finally the relationship between constipation and QOL are presented.

Predictors of Quality of Life in Cancer Patients Near the End of Life

Previous research indicates that a number of variables may affect QOL in persons
with cancer. Age has often been found to be a significant predictor with older patients
reporting higher QOL scores (Hack et al., 2010; Wald et al., 2007; Salonen, Kellokumpu
Lehtinen, Tarkka, Koivisto, & Kaunonen, 2011). A longitudinal study was conducted to
evaluate sarcoma patients’ QOL and to explore their demographic and clinical predictors
of QOL (Paredes, Pereira, Moreira, Simões, & Canavarro, 2011). Researchers used a
structured questionnaire to collect demographic and clinical data. The sample ages ranged
from 18-72 years. The majority of patients were exposed to chemotherapy during their
treatment phase, and 25% were exposed to radiation therapy. Patients scored low QOL at
baseline and treatment phase, QOL scores in the physical domain at baseline were a
significant predictor (p = 0.01) for physical functioning at treatment phase while age
(p = 0.26) marital status (p = 0.09), and professional status (p = 0.55) contributed to a
significant increase in the total of explained variance. Also there was a significant
10

relationship between symptoms such as pain and fatigue with low financial status at both
baseline and after treatment.
Predictors of QOL including patient age, education, place of living, tumor grade
and impact of initial treatment were studied by Hack and colleagues (2010). , They also
explored the interaction between predictors of distress and quality of life for cancer
patients receiving treatment. They reported a significant main effect of chemotherapy on
patients’ QOL, and age was a significant predictor of emotional wellbeing (p<0.0001).
Younger women reported worse QOL than older women. The researchers concluded that
a combination of patient factors such as older age and lack of education or lack of support
leads patients to withdraw as an adaptation mechanism to stressful situations (Hack et al.,
2010).
Gender also has been studied in relation to QOL. Females reported worse QOL,
and a combination of being older women and lack of support and lower education level
led to lower QOL scores (Hack et al., 2010; Zimmermann et al., 2010). Mystakidou and
colleagues (2005) evaluated the relationship between psychological morbidity, anxiety
and depression in 120 patients receiving palliative care. Strong relationships between
hospital anxiety and depression and patients’ emotional functioning (p< .0005) were
found. The influence of gender on physical, emotional, and social functioning and other
symptoms was high (p<.05) (Mystakidou et al., 2005).
Contemporary research indicates that patients who are employed report a lower
risk for undesirable changes in QOL than patients who are retired or unemployed; and
employed women have a better QOL than unemployed or retired women (Salonen,
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Kellokumpu Lehtinen, Tarkka, Koivisto, & Kaunonen, 2011; Kandasamy et al 2011). A
randomized, control trial conducted by Salonen et al. (2011) reported significant
predictors of patients’ QOL to be: level of education, employment status, having
children, and exposure to cancer treatments. QOL of both the intervention and control
groups of patients improved over the six-month after surgery. Body image was
significantly reduced for both the intervention (p = 0.001) and control groups (p = 0·007).
Significant systematic adverse effects were noted in the intervention group (p ≤ 0·001)
and in the control group (p = 0·003).
Although some have stated that the SF-36 is not a measure of QOL because it
measures only physical and mental well-being, investigators continue to use it. Using the
SF-36, employed subjects scored higher on QOL than unemployed or retired subjects.
Scores for employed subjects ranged around 50 in all scales while they were between 30
and 40 for the unemployed. QOL scores were lower for subjects who were living alone
compared to those who are living with families or partners especially for general health
and social functioning scales of SF-36. (Wald et al., 2007).
Georges, Onwuteaka-Philipsen, Heide, Wal and Maas. (2005) studied cancer
patients and their characteristics in their last days in a study designed to assess symptoms
and symptom management. Results showed a significant increase in symptoms such as
loss of appetite, feeling unwell, dependency and fatigue. Physicians reported that
patients’ physical symptoms were managed more than their psychosocial symptoms. The
number of medical specialties that provide care for dying patients in their last days
decreased, while other non-medical caregivers increased. The study supported that the
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participation of family members supported the terminally ill cancer patients and
facilitated their dying in peace.
Mental status has been assessed both as cognitive decline and mental well-being
(Reid-Arndt, Hsieh, & Perry, 2010; Wald et al 2007). Reid et al (2010) assessed the
effect of delicate cognitive changes on breast cancer patients’ QOL. Demographic
information, neuropsychological measures, self-reported cognitive difficulties, fatigue
and social support seeking were predictor variables. The results confirmed how important
social support was to QOL. Also analysis shown an inverse relationship between selfreported cognitive complaints and overall QOL (p= 0.08). Psychological morbidity was
largely predicted by QOL dimensions (p< .05) (Mystakidou et al., 2005). Also
ssignificant correlations have been found between QOL and physical status (Garrison,
Overcash, & McMillan, 2011). Although QOL has been studied in different nations,
research comparing cancer patients from different cultural groups are limited (Wald et al.,
2007).

Symptom Severity, Distress and Quality of Life

Researchers indicated that patient symptoms are not being successfully managed,
Symptom distress in persons with cancer has been shown to have a negative effect on
overall QOL (McMillan, 2002; Gapstur, 2007).
Some studies have shown that women report greater symptom distress than men
(p =0.005) (Zimmermann et al. 2010). Karabulu, Erci, Ozer, and Ozdemir (2010)
conducted a cross-sectional study to identify the prevalence and severity of cancer
patients’ symptoms. In this study 12.5% of patients experienced severe symptoms, while
13

37.5% experienced moderate symptoms. The most frequently reported symptoms among
a sample of hospice patients with cancer were lack of energy, pain, dry mouth, and
shortness of breath. The average intensity score was 3.13 (McMillan & Small, 2002).
To evaluate the incidence and severity of constipation in hospice patients,
researchers at the University of Texas conducted a large retrospective cohort study in a
large population-based sample of 50,641 persons who received hospice care. Moderate to
severe constipation was most dominant among terminally ill cancer patients, mostly
patients who were diagnosed with respiratory cancers, gastrointestinal or peritoneum
cancers, and genitourinary organs cancer. Constipation was also highly reported by
patients with high pain scores or patients on laxatives (Strassels, Maxwell, & Iyer, 2010).
Researchers conducted a cross-sectional study to evaluate the effect of spiritual
wellbeing on the rest of QOL dimensions, depression, and symptoms of distress in
terminally ill cancer patients (Kandasamy, Chaturvedi, & Desai, 2011). The results
showed that spiritual well-being correlated negatively with mood (r = -0.630, p < 0.001),
work (r = -0.376, p < 0.001), relationships (r = -0.624, p < 0.001), and enjoyment of life
(r = -0.681, p < 0.001). Spiritual well-being positively correlated with all the other
aspects of QOL measures p = 0.008. Patients experiencing stress and anxiety experience
significantly lower quality of life levels. (Mehnert, Lehmann, Schulte, & Koch, 2007).
Kirkova et al. (2009) conducted another study to determine the relationship
between symptom severity and distress from multiple symptoms in cancer, and to
evaluate the relationship between participants’ demographics and symptom distress.
Results showed that more than 50% of symptoms reported as distressful, younger patients
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and females showed higher levels of distress except for anxiety, the primary site group
does not affect distress, and the prevalence of distress increased with greater symptom
severity.
McMillan and Small (2002) evaluated symptom distress and quality of life in
patients with cancer newly admitted to hospice home care. The results showed that lack
of energy caused the greatest distress, followed closely by dry mouth and pain. The
results of the regression analysis indicated constipation intensity was related to QOL at
the univariate level. When all predictors were considered simultaneously, only the total
distress score remained a significant predictor of QOL (p < 0.001), accounting for about
35% of variance. The authors concluded that QOL was affected by symptom distress in
people with advanced cancer near the end of life.
To study the incidence and character of problems relating to cancer and treatment
and their association with symptom distress a group of researchers Recommendations
were made for health care professionals to consider family caregiver’s assessments of
patients’ symptom distress when the patient is unable to provide his/her own symptom
distress self-report. A percentage of 53% of patients reported experiencing emotional
distress and/or anxiety related to prostate cancer (Mehnert, Lehmann, Schulte, & Koch,
2007).

Constipation and Cancer

Constipation is common in patients with cancer because of their many risk
factors, and in a cancer patient receiving opiates, constipation is inevitable.
Unfortunately, this potentially serious problem is often overlooked and under-managed.
15

(McMillan, 2004). It is known that constipation causes symptom distress, and this
distress affects the QOL of cancer patients and their care givers (Kinzbrunner, Weinreb,
Policzer 2002; Ferrell, Coyle 2006).
In a descriptive cross sectional study conducted in palliative care settings in
Spain, researchers aimed to evaluate the effectiveness of laxative treatment and if there is
a relationship between constipation and opioids. In this study 91% patients were
diagnosed with cancer and the constipation prevalence was the highest among them.
(Noguera, Centeno, Librada, & Nabal, 2010).
The impact of opioid induced bowel dysfunction in patients treated with opioids
for pain and were on laxative has been assessed by a multinational survey online
designed by Bell, Panchal, and Miaskowski (2009). The bowel dysfunction symptoms
reported in this study by most patients four times a week with a highest severity, and also
patients stated the impact of bowel dysfunction on their daily life activities and so on
their quality of life. Around 30% of patients neglected their opioids doses or started
noncompliance with this treatment in order to have better bowel motility. This study
supported the idea that the opioid induced bowel dysfunction incidence is high even the
patients taking laxative and patients experienced new symptoms in addition to
uncontrolled pain that affects the level of their quality of life.

Constipation and QOL Among Cancer Patients

Wald et al. (2007) studied QOL in a multinational survey to compare different
social and demographic groups with and without constipation and to detect country-
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specific differences among the groups studied, and to assess the impact of constipation on
quality of life. Health-related QOL (HRQOL) was assessed with the Short Form 36 (SF36) questionnaire in 2870 subjects in France, Germany, Italy, UK, South Korea, Brazil
and USA. Results in all countries showed that QOL scores correlated negatively with
age, and there were significant differences in HRQOL between constipated and nonconstipated individuals and a significant, negative correlation between the number of
symptoms and complaints and SF-36 scores. The study showed also a significant
relationship between constipation and QOL and the influence of social and demographic
factors on HRQOL in constipated people.
Chronic constipation will lead to incapacitating symptoms. Health care providers
usually failed to treat constipation with laxatives, causing negative effects on the patients
quality of life (Quigley, Vandeplassche, Kerstens and Ausma, 2009; Outryve, Beyens,
Kerstens, and Vandeplassche, 2009; Tong, Isenring and Yates, 2009).
Summary
The literature showed a significant relationship between constipation and QOL
and an influence of social and demographic factors on QOL of constipated patients. The
distress caused by constipation has an impact as well on patients’ QOL.
Constipation is a serious problem for cancer patients near the end of life, but the
literature does not address the distress caused by constipation and the effect of this
distress on hospice patient's quality of life. Thus, there is a need for further clarification
of constipation and predictors and outcomes connected with it.
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Chapter Three: Methods
Research Design
This chapter presents the methods used in this study. This study was a descriptive,
correlational design and a secondary analysis of data from an earlier study (McMillan,
Small, & Haley, 2010). The aim of the original experimental intervention study was to
evaluate the effectiveness of using standardized assessment tools in order to provide
systematic feedback from hospice patients and their caregivers. The researchers
hypothesized that there would be significant differences in hospice outcomes between the
experimental and the control groups. The researchers used data from 709 cancer patients
and their caregivers who had been admitted to one of the two large private not-for-profit
hospices. In both settings the patients received comprehensive services delivered by the
hospice Interdisciplinary teams. This proposed project is a non-experimental quantitative
study using previously gathered data to test a new hypothesis with alternative strategies
to examine relationships not previously analyzed.
Sample and Setting
The target population was patients who receive homecare from a large nonprofit
hospice; the convenience sample was 310 patients. Power analytic techniques indicated
that with the sample size, with power set at .90 and alpha set at .05, a small to medium
effect size could be detected. In this study, all patients met the following inclusion
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criteria; adults diagnosed with cancer who had an identified family caregiver; patients
who were able to read and understand English, and able to pass mental status screening.
The setting for the study was two large nonprofit hospices that primarily provide home
care. The study was approved by the Hospice Bioethics Committees and the University
Institutional Review Board.
Instruments
Five instruments were used in this study to operationalize the variables of interest.
They were the Memorial Symptom Assessment Scale, the Palliative Performance Scale,
the Short Portable Mental Status Questionnaire, the Hospice Quality of Life Index, and a
Patient Demographic Date Form.
The Memorial Symptom Assessment Scale (MSAS). The MSAS was used to
measure constipation symptom presence, intensity and distress. Twenty-five symptoms
are measured, including constipation. Patients mark the form indicating which symptoms
they are currently experiencing. Item scores for both intensity and distress range from 0
to 4 with 4 being greater intensity or distress due to constipation. The construct validity
was evaluated by correlating MSAS scores and quality of lifeQOL. As predicted, there
was a strong negative correlation (r=-0.72). Coefficient alpha was used to evaluate
reliability and it was good (r= 0.73-0.74) (McMillan & Small, 2002).
The Hospice QOL Index-14 (HQLI-14). is a shortened version of previously
used and validated 28-item Hospice Quality of Life Index (HQLI). It has 14 items; each
item is scored on a 0-10 scale; the total score is obtained by adding item scores which
range from 0-140, while 0 reflects the worst QOL that could be measured and 140 is the
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best QOL. The factor analysis of the HQLI revealed three factors which
included: psycho-physiological, functional and social/spiritual wellbeing. Concurrent
validity was supported by correlation which was analyzed in a hospice sample prior to the
beginning of the study. Construct validity was evaluated by correlation with the original
HQLI (r= 0.94, p< 0.001) (Buck, Overcash, & McMillan, 2009). Reliability of the HQLI
was provided by generation of coefficient alphas for both total scale scores and subscale
scores, Subscale alphas were .84 and the total alpha when it used with cancer patients
was (r=.88) (McMillan & Mahon, 1994).
Palliative Performance Scale (PPS). The PPS was used to measure the
functional status for patients. The PPS was developed by the Victoria Hospice Society in
1999. The PPS assesses a patient’s level of ambulation, activity, evidence of disease, selfcare, intake, and consciousness. Patients can score between 0-100%; while 0 means death
and 100 reflects a person with normal activity level. The PPS scale was designed to
assess a patient’s functional level and the needs of palliative care patients. Construct
validity was supported by the strong positive correlation between PPS and Karnofsky
Functional Status (r= 0.93) (McMillan et al., 2010).Strong correlations were found
between the scores rated by an oncologist, radiation therapist, and a research assistant
(r=0.69-0.86). In addition, good reliability as measured by the alpha coefficient was
reported (Campos et al., 2009).
Short Portable Mental Status Questionnaire (SPMSQ). Measures the presence
of intellectual impairment and the degree of impairment in patients. Scores range from 0
to 10; a cutoff score of 8 was used in this study. This is a valid instrument to be used for
detecting moderate to severe cognitive impairment in cancer patients (MacNeil &
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Lichtenberg, 1999). Evidence was found for the reliability and reliability coefficients
were greater than 0.80 (Pfeiffer, 1975).
Demographic Data Form. Included gender, age, race/culture, marital status,
income, educational level, type of cancer, and physical/mental health status.
Procedures
For the parent study, the patients were identified by the research assistants, who
were nurse data collectors who had been hired for the original study. These research
assistants visited the homes of patients, consented the patients, and collected baseline
data (McMillan, Small, & Haley, 2010).
For this secondary analysis, data was obtained from Dr. McMillan, who gave
permission for its use. Data was cleaned by reviewing for missing data and by randomly
selecting cases for double entry. Means of the cases that were double-entered compared
with the sample means from patients already entered. If differences were found, the
original data from the paper copies were reviewed to find the errors. These errors were
corrected. Patients with missing data eliminated from the data set. The revised data set
used for this proposed secondary analysis.
Data Analysis
This study was conducted through secondary analysis of data. First, data was
analyzed using descriptive statistics, so the frequency, percentage, means and standard
deviations for quality of life for the overall sample of hospice cancer patients were
calculated along with all other variables. Correlation coefficients between quality of life
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and patients' socio-demographic variables and between quality of life and clinical
characteristics also were calculated.
Multivariate regression analysis was conducted using QOL as the dependent
variable, and age, gender, education, functional and mental status, cancer diagnosis, and
constipation severity as the predictor variables. An exploratory mediation analysis was
used to assess the mediation effect of the constipation distress. A mediator can be
explained as a transmitter of the effect of an independent variable (IV) on the dependent
variable (DV). So the IV affects the DV because the IV affects the mediator, and the
mediator in sequence affects the DV. (Preacher, Rucker, & Hayes, 2007). Statistical
significance of the mediated effect can be calculated by dividing the estimate by its
standard error and comparing the result with the standard normal distribution. For nonnormality of data, both confidence limits for mediated effects and re-sampling methods
could be used (MacKinnon & Fairchild, 2009). The bootstrapping method was used to
measure the mediating variable effects because this method has high power and it does
not make an assumption about normality compared to the Sobel test or Baron and Kenny
test (Hayes, 2009).
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Chapter Four: Results

The purpose of the proposed study was to determine, using an existing data set,
predictors of QOL and to evaluate the mediating effect of constipation distress in patients
who receive homecare from a large nonprofit hospice. This chapter includes three
sections; the first section represents description for demographic variables and clinical
characteristics regarding cancer diagnosis, constipation severity and intensity, and
patient’s physical and mental health. In the second section, correlations between the
predictors of QOL and the overall QOL; and the third section represent the mediation
analysis.
Sample
The sample consisted of 310 patients; the majority of whom were white (96.9%)
(Table 1). The sample had slightly more males (55.3%) than females. Patients in this
sample tended to be married (63.6%), and the majority of patients in this sample were
living with someone (93.4%). The patients’ ages ranged between 21 and 95 years old,
with a mean age of 72.7 years (SD= 12.1). Only 4.1 % of the patients in the sample were
under 50 years old, and more than half of this sample were 70 years and older. The level
of education among these patients was assessed by asking about the number of years of
education. The mean was 12.7 years of education (SD= 2.9) (Table 2). The most common
site for primary cancer was the lung (34%) (Table 1).
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Table 1. Frequency and Percent of Patients by Demographic Variables
Variable

Frequency

Percent

Male

171

55.3

Female

138

44.7

Currently married

203

63.6

Not-married

107

18.5

White

299

96.9

Other

11

0.4

Lung

105

34.0

GI/Colorectal

79

25.6

Genitourinary

33

10.9

Breast

16

5.6

Gynecological

15

5.2

Other

62

18.6

Reported Constipation

310

44.5

Gender

Marital Status

Ethnicity

Cancer Diagnosis
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Table 2. Means and Standard Deviations of Patients’ Age, Education, PPS Scores,
Constipation Severity Scores and Constipation Distress Scores
Variable

Mean

Standard Deviation

Age

72.7

12.1

Years of Education

12.7

2.9

Physical Function (PPS)

57.1

10.9

Mental Status (SPMSQ)

9.23

0.9

Constipation Severity

2.44

1.1

Constipation Distress

2.47

1.3

QOL Scores

102.2

17.4

Descriptive Statistics
Constipation was present among 44.5% of the patients in the sample (Table 1).
According to the sample, the mean for constipation severity was 2.44 (SD= 1.1), and the
mean for constipation distress was 2.47 (SD= 1.3). PPS was used to evaluate patients’
physical health. The mean score was 57.1 (SD= 10.9), while the SPMSQ was used for
patients’ mental health evaluation, and yielded a mean score of 9.23 (SD= 0.9). Mean
quality of life was 102.7 (SD=17.4) (Table 2).
Correlations
Bivariate correlations were calculated between QOL total scores and the target
variables Weak significant correlations were found between QOL and patients’ age and
education. Weak but significant correlations were found between PPS and SPMSQ, and
between years of education and SPMSQ. There was also a significant negative
correlation between constipation severity and QOL total (p=0.01), and another significant
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correlation of 0.25 between constipation distress and QOL total (p=0.01). Finally, there
was a significant strong correlation of 0.69 between constipation severity and
constipation distress (p=0.01).
Predictors
A regression analysis using bootstrapping method was done to answer question
number one: Do socio-demographic variables age, gender, marital status, race/culture,
education, and socioeconomic status), clinical characteristics (type of cancer, physical
and mental status) and constipation intensity predict quality of life in hospice patients
with cancer? The results showed that age, ethnicity, constipation severity and functional
status were significant predictors for QOL (P<0.05) (Table 4).
Mediation
The bootstrapping method was used to measure the mediating variable effects and
significance. The bootstrapping analysis revealed direct, partial and total effects with
standard errors and significance. This analysis was done to answer question number two:
To what extent does constipation distress serve as a mediator in the relationship between
constipation intensity and overall quality of life in hospice patients with cancer? Results
are presented in Table 4.
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Table 3: Pearson Correlation Coefficients between the Predictors and the QOL.
PSMSQ

Patients
Age

PPS
Total

Years of Constip. Constip.
education Severity Distress

QOL

-0.11c
(307)

0.24c
(309)

0.19c
(308)

-0.10
(310)

-0.03
(310)

-0.02
(302)

-0.09b
(306)

-0.06
(305)

-0.08
(308)

-0.07
(308)

0.18 c
(299)

-0.04
(704)

-0.11
(310)

-0.02
(310)

0.18 c
(301)

0.03
(309)

0.06
(309)

-0.12 c
(300)

0.69c
(311)

-0.24c
(302)

PSMSQ
r
n
Patients Age
r
n
PPS Total
r
n
Years of
education
r
n
Constipation
Severity
r
n
Constipation
Distress
-0.25c
(302)

r
n
QOL
r
n
a
b

P< 0.05
P<0.01
A significant relationship between the dependent variable, QOL, and the

independent variable, constipation severity, was found (p<0.05). Both, the direct effect of
the independent variable on the mediator, constipation distress, as well as the direct effect
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of the mediator on the dependent variable, were significant (p<0.05). However, the direct
path between the independent variable and dependent variable with the mediator was not
significant (p=0.24), which, according to Baron and Kenny, indicates that constipation
distress mediates the effect of constipation severity on the QOL (Baron & Kenny, 1986)
(Table 3).
Table 4: Direct, Partial, and Total Effects of Bootstrapping Mediation Analysis.
Unstandardized
Coefficient
N= 296

Standard
error

P

Effect
Effect of IV on mediators

0.79

0.05

0.00

Direct effect of mediator
on DV

-1.98

0.99

0.04

Total effect of IV on DV

-2.91

0.85

0.00

Direct effect of IV on DV

-1.35

1.15

0.24

Age

0.23

0.08

0.00

Gender

-0.14

1.90

0.94

Education

-0.52

0.31

0.09

PPS total

0.19

0.09

0.04

SPMSQ

0.99

1.06

0.36

Ethnicity

-11.44

5.34

0.03

Cancer Diagnosis

-0.71

1.99

0.72

QOL Predictors
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Bootstrapping analysis revealed a significant effect of the following control
variables (covariates) on the QOL: age, PPS score, and ethnicity; all of these variables
were significant at less than 0.05 levels. On the other hand, gender, education, SPMSQ,
living arrangement, and type of cancer were not significant.
In this analysis, constipation distress was proposed as a mediator between
constipation severity and QOL. The number of bootstrap resamples was 5000. The biascorrected confidence interval on the 95% level of confidence showed that constipation
distress had a mediation effect on the relationship between constipation severity and
QOL. (Table 3)
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Chapter Five: Discussion, Conclusions, and Recommendations
Discussion
The purpose of this study was to determine, using an existing data set, predictors
of QOL and to evaluate the mediating effect of constipation distress in patients who
receive homecare from a large non-profit hospice. This study was designed to address the
following questions: To what extent does constipation distress serve as a mediator in the
relationship between constipation intensity and overall quality of life in hospice patients
with cancer?
Patients with cancer often experience constipation which may be a result of the
cancer, low fiber diet, lack of activity or opioids (McMillan, 2004). In this study, both
severity and distress from constipation were evaluated. The characteristic of symptom
distress is known as the degree of discomfort associated with a symptom experienced by
the patient (Sarna, Lindsey, Brecht, Dean, & McCorkle, 1994). Analyzing all symptom
dimensions reflects the patient's interpretation of a symptom (Molassiotis, Wengstrom, &
Kearney, 2010)
Constipation is common in patients with cancer because of their many risk
factors, and in a cancer patient receiving opiates, constipation is inevitable.
Unfortunately, this potentially serious problem is often overlooked and under-managed.
(McMillan, 2004). In this study 44.5% of the patients reported having constipation, and
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more than 70% of patients with constipation described the severity as 2 or more on a
scale from 0-4. This moderate to severe level of constipation was also dominant in a
study conducted with a large hospice population of 50,641 patients (Strassels et al, 2010).
The literature supported that distress has an impact on the people with advanced
cancer near the end of life QOL (McMillan & Small 2002). The patients on the study
were asked about how much distress they had because of constipation; 92.6% had
reported a level of distress that ranged from one to four with a 2.47 mean on a scale from
0-4. The level of distress in this study was congruent with the literature which showed a
percentage of 50%-53% of patients experienced distress caused by their symptoms
(Kirkova et al, 2007, Mehnert et al 2007). This means that both, the symptom intensity
and distress as well as the relationship between constipation and quality of life need to be
considered when nurses manage patients to achieve the best symptom management for
cancer patients. A limitation for the study is that the constipation variables were asked
and evaluated on a single scale from 0 to 4; this single item scale may not reflect all the
clinically important signs and symptoms of constipation.
The study included 310 cancer patients near the end of life; however, less than
half reported constipation on the MSAS leaving a sample of 310 for the mediation
analysis. The sample had a wide range of different age groups, ranging between 21 and
95 years old, and the mean age was 72.7 years. Although there was a wide range of ages,
only 4.1 % of the patients in the sample were under 50 years old, and more than half of
this sample were 70 years and older. The fact that the majority of patients in this study
were over 70 years old may affect the generalizability of the study to all cancer patients.
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Patients within this sample came from different ethnic backgrounds, including
African-American, Hispanic, Asian-Pacific Islander, and white. However, the great
majority of the patients (97%) were white. Thus, results are not generalizable to all
cancer patients because cancer affects people of all races and ethnicities. This result
probably occurred because relatively small numbers of minority cancer patients seek
hospice services. Future studies should attempt to include larger numbers of minority
patients. The majority of patients were living with someone and not alone. This finding
was the result of the way in which patients were identified in the original study; all
patients had to have a family caregiver. Thus, these results are not generalizable to
patients who do not have family caregivers, who are receiving hospice care in nursing
homes or assisted living facilities, or who are residing in a hospice house. The patients
reported a fairly high level of quality of life (mean = 102.2; SD=17.4), which represents
73% of the highest score of 140. This score is similar to the mean of another group of 255
hospice patients with cancer studied earlier (McMillan & Weitzner, 1998).
The study yielded that age has a significant negative relationship with QOL
(P<0.05) and this was supported by previous research (Hack et al., 2010). Age and
ethnicity were significant predictors that correlated with the cancer patients’ QOL.
The SPMSQ was used as a screening instrument for cognitive impairment, and as
a result the patients in the study had relatively high cognitive function; that is, patients
with lower mental status were screened out of the study. This restricted range problem
may explain why this relationship between mental health and QOL was not significant
while the literature supported the influence of the patients’ mental health on their overall
QOL (Kandasamy, 2011).
32

In this study the patients’ mean score for their physical status was 57.1
(SD=10.9), which means that they were fully conscious, but they needed occasional
assistance with self-care, and their significant disease reduced their ambulation and
activity level. Again, this variable had a restricted range because patients with scores
below 40 were excluded from the study. Never-the-less, patients’ physical status
correlated positively with their QOL (P<0.01) as might be expected.
The more severe constipation became the lower were the QOL scores reported;
this seems like a reasonable finding; that is, it should be expected that as a symptom
increases in intensity, the distress also would increase and would have a negative effect
on the QOL. The strongest correlation in this study was found between constipation
severity and constipation distress 0.69 (P<0.01), in an earlier study the researcher
concluded that constipation distress increased with increasing its severity, and 69% of
patients with constipation complained from high level of constipation distress (Kirkova et
al, 2006).
In order to evaluate the mediation effect of constipation distress between the
predictor variables and QOL, a bootstrapping mediation analysis was used rather than
both Baron and Kenny’s or Sobel’s approach. An extra analysis done based on Baron and
Kenny reflected a significant direct path between the constipation severity and QOL
(P=0.00) and a trend of mediation effect on the direct path with the constipation distress
as a mediator. The benefits of bootstrapping methods are the higher power and that
bootstrapping does not make an assumption about normality. The patients’ age, gender,
education, physical and mental health, ethnicity and type of cancer were covariates
controlled for in the regression analysis.
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The mediation effect was significant when the level of confidence for confidence
intervals was 95% and number of bootstrap resamples was 5000. With this new
information that constipation distress mediates the relationship between constipation
intensity and QOL, nursing has additional evidence of the importance of symptom
distress. Thus, nurses should assess constipation intensity but also should determine the
extent to which it is distressing to the patient. If this is the case for constipation, it may
also be true for other symptoms.
Conclusions and Recommendations
Cancer patients suffer from many symptoms that could be related to the cancer
itself or the cancer treatments. The symptom intensity and distress as well as the
relationship between constipation and quality of life need to be seen in a holistic
approach to achieve the best symptom management for cancer patients. Oncology nurses
should consider the predictors of the patients’ QOL in order to identify patients who may
be at risk for poor future QOL.
Committed individuals have already conducted some important research in
symptom management and end of life care for cancer patients (McMillan et al, 2010), but
the relationships between the symptom and their effect on patients and also between all
symptoms need to be addressed more in the literature. The sample as mentioned before
was mostly white, alert and functioning, and further biased by having family around
them. Further studies should be conducted to learn about patients who are from minority
groups, are not mentally or functionally capable and who have less available support
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systems. In addition, developing better tools for assessing the symptom experience may
help in improving symptom distress management and alleviating patients suffering.
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